flucytosine has been researched along with 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2h-tetrazolium in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Becker, G; Braun, K; Corban-Wilhelm, H; Debus, J; Ehemann, V; Greulich, D | 1 |
1 other study(ies) available for flucytosine and 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2h-tetrazolium
| Article | Year |
|---|---|
Comparison of different methods to assess the cytotoxic effects of cytosine deaminase and thymidine kinase gene therapy.
Topics: Animals; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Survival; Cytosine Deaminase; Escherichia coli; Flucytosine; Ganciclovir; Gene Transfer Techniques; Genes, Transgenic, Suicide; Genetic Therapy; Herpesvirus 1, Human; Male; Prostatic Neoplasms; Rats; Recombinant Fusion Proteins; Tetrazolium Salts; Thiazoles; Thymidine Kinase; Toxicity Tests; Tumor Stem Cell Assay | 2004 |